Your browser doesn't support javascript.
loading
Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies.
Eichenauer, Dennis A; Bühnen, Ina; Baues, Christian; Kobe, Carsten; Kaul, Helen; Greil, Richard; Moccia, Alden; Zijlstra, Joseé M; Hertenstein, Bernd; Topp, Max S; Just, Marianne; von Tresckow, Bastian; Eich, Hans-Theodor; Fuchs, Michael; Dietlein, Markus; Hartmann, Sylvia; Engert, Andreas; Borchmann, Peter.
Afiliación
  • Eichenauer DA; First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany.
  • Bühnen I; German Hodgkin Study Group, University Hospital Cologne, Cologne, Germany.
  • Baues C; First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany.
  • Kobe C; German Hodgkin Study Group, University Hospital Cologne, Cologne, Germany.
  • Kaul H; German Hodgkin Study Group, University Hospital Cologne, Cologne, Germany.
  • Greil R; Department of Radiation Oncology, University of Cologne, Cologne, Germany.
  • Moccia A; German Hodgkin Study Group, University Hospital Cologne, Cologne, Germany.
  • Zijlstra JM; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Hertenstein B; First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany.
  • Topp MS; German Hodgkin Study Group, University Hospital Cologne, Cologne, Germany.
  • Just M; Salzburg Cancer Research Institute, Center for Clinical Cancer and Immunology Trials, Cancer Cluster Salzburg, Austrian Group for Medical Tumor Therapy, Paracelsus Medical University, Salzburg, Austria.
  • von Tresckow B; Department of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Eich HT; Swiss Group for Clinical Cancer Research, Bern, Switzerland.
  • Fuchs M; Department of Hematology, Amsterdam UMC, Vrije universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Dietlein M; Department of Internal Medicine I, Klinikum Bremen-Mitte, Bremen, Germany.
  • Hartmann S; Second Department of Internal Medicine, University Hospital Würzburg, Würzburg, Germany.
  • Engert A; Onkologische Schwerpunktpraxis Bielefeld, Bielefeld, Germany.
  • Borchmann P; German Hodgkin Study Group, University Hospital Cologne, Cologne, Germany.
Blood ; 142(6): 553-560, 2023 08 10.
Article en En | MEDLINE | ID: mdl-37257195
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Blood Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Blood Año: 2023 Tipo del documento: Article País de afiliación: Alemania